Germany's premier gathering for the biopharma community dedicated to propelling bioprocessing innovation and market expansion.
Germany ranks fourth globally in biopharmaceuticals, with over 650 biotechnology companies. Its collaboration among industry, government, and research sectors, along with bioregions, propels the sector forward. The increasing prevalence of chronic diseases and an aging population have boosted demand for biologic drugs, leading to an 8% annual growth in prescriptions. Recent advancements made by Calidi Biotherapeutics, Eleva Biologics and Roche underscore Germany's appeal, thanks to its strategic location, skilled workforce, advanced infrastructure, and government incentives.
Biologics Manufacturing Germany 2025 will delve into advancements in biomanufacturing and examine how rising operational complexity and uncertainty impact long-term decision-making. Topics will include risk mitigation, regulatory changes, and CMO partner selection, especially in light of automation, AI, and sustainability. These discussions are crucial for stakeholders in the biologics manufacturing industry, providing valuable insights on navigating challenges and making informed decisions in a complex and dynamic environment.
CONFERENCE LEARNING POINTS
*STANDRAD RATE Valid until 7 February 2025 FINAL CALL: £2650 (+VAT) From 08 February 2025 - 16 February 2025 Value Added Tax (VAT) exemptions will be applied where applicable in accordance with relevant regulations
*STANDRD RATE
Valid until 7 February 2025
FINAL CALL: £1550 (+VAT)
From 08 February 2025 - 16 February 2025
Value Added Tax (VAT) exemptions will be applied where applicable in accordance with relevant regulations
Representatives of service, solution, and technology providers are welcome to attend Biologics Manufacturing Germany 2025
Get in touch and download the prospectus for detailed information on attendance options, sponsorship opportunities and benefits, and how to maximise your presence at #BMG2025
Get in touch by e-mail: [email protected]
*STANDRAD RATE Valid until 7 February 2025 FINAL CALL: £2650 (+VAT) From 08 February 2025 - 16 February 2025 Value Added Tax (VAT) exemptions will be applied where applicable in accordance with relevant regulations
*STANDRD RATE
Valid until 7 February 2025
FINAL CALL: £1550 (+VAT)
From 08 February 2025 - 16 February 2025
Value Added Tax (VAT) exemptions will be applied where applicable in accordance with relevant regulations
Representatives of service, solution, and technology providers are welcome to attend Biologics Manufacturing Germany 2025
Get in touch and download the prospectus for detailed information on attendance options, sponsorship opportunities and benefits, and how to maximise your presence at #BMG2025
Get in touch by e-mail: [email protected]
IMAPAC is the go-to holistic producer of live events, biopharma data and digital marketing solutions for the global biopharmaceutical industry.
© 2024 Imapac. All rights reserved. Trade marks are owned by or licensed to imapac.
IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.
IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.